Market Cap 145.84B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.09
Forward PE 8.74
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 59,470,500
Avg Vol 60,520,750
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 66%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
forasi6170
forasi6170 Jan. 19 at 7:59 PM
$PFE marketinsight.us/trading-structure-analysis-and-market-updates.html
0 · Reply
DailyAnalysis
DailyAnalysis Jan. 19 at 6:32 PM
$PFE is coiling. RSI at 55 and Stochastics near 48 show momentum resetting, leaving ample upside room. With CCI holding positive, the trend structure is intact. This is accumulation, not a top. @DailyAnalysis
0 · Reply
Shorting_BTC_Since_2009
Shorting_BTC_Since_2009 Jan. 19 at 6:25 PM
$IBRX exactly this. We all need to do this. Tag other stocks people!!! $MRK $JNJ $PFE $PILL
0 · Reply
Kgra
Kgra Jan. 19 at 6:10 PM
$PFE https://www.trefis.com/stock/pfe/articles2/587142/what-could-send-pfizer-stock-soaring-3/2026-01-09
0 · Reply
Kgra
Kgra Jan. 19 at 5:55 PM
$PFE https://www.ad-hoc-news.de/boerse/news/ueberblick/major-funds-accumulate-pfizer-shares-amid-valuation-shift/68500437
0 · Reply
taxplanr
taxplanr Jan. 19 at 4:07 PM
$PFE latest gabapentin lawsuits info https://allaboutlawyer.com/gabapentin-lawsuit-2025-new-dementia-research-sparks-legal-claims-as-recalls-hit-pharmacies-nationwide/
1 · Reply
ZacksResearch
ZacksResearch Jan. 19 at 2:02 PM
$PFE: Are We Seeing a Value Opportunity in Pfizer? 🤔 Despite a 2.5% decline in the past year, Pfizer's shares are trading at a forward P/E of 8.58, well below the industry average of 17.73 and its five-year mean of 10.31. 📉💡 Explore the full investment case here 👉 https://www.zacks.com/stock/news/2819418/what-to-expect-from-pfizers-non-oncology-business-in-q4?cid=sm-stocktwits-2-2819418-body-29423&ADID=SYND_STOCKTWITS_TWEET_2_2819418_BODY_29423
0 · Reply
ZacksResearch
ZacksResearch Jan. 19 at 1:02 PM
Mixed signals heading into earnings for $PFE — is the market focused on the right driver? ⚖️ The Q4 outlook highlights Eliquis growth as a key positive, while COVID-19 sales are softer and demand for core non-oncology drugs remains steady ahead of earnings. See how this balance could shape the earnings reaction 👉 https://www.zacks.com/stock/news/2819418/what-to-expect-from-pfizers-non-oncology-business-in-q4?cid=sm-stocktwits-2-2819418-teaser-29417&ADID=SYND_STOCKTWITS_TWEET_2_2819418_TEASER_29417
0 · Reply
taxplanr
taxplanr Jan. 19 at 3:18 AM
$PFE https://www.tiktok.com/t/ZThkk87s1/
1 · Reply
taxplanr
taxplanr Jan. 19 at 2:18 AM
You never know who is going to ruin an oncology pipeline ... or do you $BNTX $MRNA $PFE https://x.com/DrPatrick/status/2011950458877734921
0 · Reply
Latest News on PFE
MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 1 hour ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT


Pfizer: Rebound Has Just Started

Jan 16, 2026, 1:08 PM EST - 3 days ago

Pfizer: Rebound Has Just Started


Pfizer: The Most Intriguing Value Play Of 2026

Jan 15, 2026, 8:58 AM EST - 4 days ago

Pfizer: The Most Intriguing Value Play Of 2026


Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 12 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK


Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 17 days ago

Pfizer 2026: The Reset Year


Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 4 weeks ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound


Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 4 weeks ago

Pfizer Stock Can Sink More. Here Is How


Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 4 weeks ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript


Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 4 weeks ago

Pfizer falls on disappointing guidance


Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 4 weeks ago

Here's why Pfizer is revising its revenue forecasts


Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 5 weeks ago

Pfizer Declares First-Quarter 2026 Dividend


forasi6170
forasi6170 Jan. 19 at 7:59 PM
$PFE marketinsight.us/trading-structure-analysis-and-market-updates.html
0 · Reply
DailyAnalysis
DailyAnalysis Jan. 19 at 6:32 PM
$PFE is coiling. RSI at 55 and Stochastics near 48 show momentum resetting, leaving ample upside room. With CCI holding positive, the trend structure is intact. This is accumulation, not a top. @DailyAnalysis
0 · Reply
Shorting_BTC_Since_2009
Shorting_BTC_Since_2009 Jan. 19 at 6:25 PM
$IBRX exactly this. We all need to do this. Tag other stocks people!!! $MRK $JNJ $PFE $PILL
0 · Reply
Kgra
Kgra Jan. 19 at 6:10 PM
$PFE https://www.trefis.com/stock/pfe/articles2/587142/what-could-send-pfizer-stock-soaring-3/2026-01-09
0 · Reply
Kgra
Kgra Jan. 19 at 5:55 PM
$PFE https://www.ad-hoc-news.de/boerse/news/ueberblick/major-funds-accumulate-pfizer-shares-amid-valuation-shift/68500437
0 · Reply
taxplanr
taxplanr Jan. 19 at 4:07 PM
$PFE latest gabapentin lawsuits info https://allaboutlawyer.com/gabapentin-lawsuit-2025-new-dementia-research-sparks-legal-claims-as-recalls-hit-pharmacies-nationwide/
1 · Reply
ZacksResearch
ZacksResearch Jan. 19 at 2:02 PM
$PFE: Are We Seeing a Value Opportunity in Pfizer? 🤔 Despite a 2.5% decline in the past year, Pfizer's shares are trading at a forward P/E of 8.58, well below the industry average of 17.73 and its five-year mean of 10.31. 📉💡 Explore the full investment case here 👉 https://www.zacks.com/stock/news/2819418/what-to-expect-from-pfizers-non-oncology-business-in-q4?cid=sm-stocktwits-2-2819418-body-29423&ADID=SYND_STOCKTWITS_TWEET_2_2819418_BODY_29423
0 · Reply
ZacksResearch
ZacksResearch Jan. 19 at 1:02 PM
Mixed signals heading into earnings for $PFE — is the market focused on the right driver? ⚖️ The Q4 outlook highlights Eliquis growth as a key positive, while COVID-19 sales are softer and demand for core non-oncology drugs remains steady ahead of earnings. See how this balance could shape the earnings reaction 👉 https://www.zacks.com/stock/news/2819418/what-to-expect-from-pfizers-non-oncology-business-in-q4?cid=sm-stocktwits-2-2819418-teaser-29417&ADID=SYND_STOCKTWITS_TWEET_2_2819418_TEASER_29417
0 · Reply
taxplanr
taxplanr Jan. 19 at 3:18 AM
$PFE https://www.tiktok.com/t/ZThkk87s1/
1 · Reply
taxplanr
taxplanr Jan. 19 at 2:18 AM
You never know who is going to ruin an oncology pipeline ... or do you $BNTX $MRNA $PFE https://x.com/DrPatrick/status/2011950458877734921
0 · Reply
taxplanr
taxplanr Jan. 19 at 2:07 AM
Even grandma 's get what the malignantRNA nano particles were for $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThkrqxG3/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 19 at 2:06 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 13 2026 Buy in Price: $0.40 - $0.45 Sell Price: $0.69 Profit : +73% (Turn every $1 into $1.73) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
taxplanr
taxplanr Jan. 18 at 9:23 PM
1 · Reply
JBS_84
JBS_84 Jan. 18 at 9:01 PM
$PFE The downtrend for these is over. Mainly for pfe.
0 · Reply
Kgra
Kgra Jan. 18 at 8:19 PM
$PFE https://finance.yahoo.com/news/investing-10-000-5-ultra-100400088.html
0 · Reply
DailyAnalysis
DailyAnalysis Jan. 18 at 7:56 PM
$PFE is technically pristine. Price reclaiming the 50 and 200-day EMAs confirms a structural trend shift. RSI at 55 screams "room to run" before exhaustion. Volume delta supports the move. Ignore the noise—the signals point to active accumulation. @DailyAnalysis
0 · Reply
Kgra
Kgra Jan. 18 at 6:28 PM
$PFE https://www.fool.com/investing/2026/01/17/best-dividend-stocks-to-buy-and-hold-pfizer-ups/
0 · Reply
BlueTegu
BlueTegu Jan. 18 at 2:34 PM
1 · Reply
taxplanr
taxplanr Jan. 18 at 1:31 PM
Peer reviewed Published Protocol for beating cancer with re-purposed dewormers $BNTX $MRNA $PFE https://www.onedaymd.com/2024/10/ivermectin-fenbendazole-and-mebendazole.html?m=1
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 18 at 10:06 AM
👀 5 Stocks With Upcoming Catalysts: 1️⃣ $NVDA – Earnings incoming. AI demand commentary could spark a big move 🚀 2️⃣ $IBRX – Cancer drug momentum + updates = volatility ahead 🧬 3️⃣ $RGEN – Gene therapy data & 2026 milestones. High-beta setup 🧪 4️⃣ $PFE – Obesity & vaccine pipeline news on deck. Big headline risk 💊 5️⃣ $GE – Earnings + aerospace/defense strength. Institutions are watching ✈️ If this helps, tap @QuantitativeTrading_
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 18 at 9:47 AM
🚨 2026 Dividend Stocks to Hold for the Long Game 💎 These aren’t flashy, but $PFE$VZ$UPS provethat patience pays. Dividend stocks often outperform over time because they combine cash flow, discipline, and resilience in downturns. If this helps, tap @QuantitativeTrading_ 1️⃣ Pfizer ($PFE) – High yield + rebound potential • Dividend: 6.8% | Forward P/E: 8.5 • Strong pipeline including GLP-1 drugs • Takeaway: Cheap cash machine with upside if pipeline delivers ⚠️ Risks: R&D setbacks, regulatory hurdles 2️⃣ Verizon ($VZ) – Slow & steady • Dividend: 6.9%, 19 years of increases • 146M+ subscribers, near-total US coverage • Takeaway: Predictable income, pays through downturns ⚠️ Risks: High interest rates ✅ Key theme: Cash generators, pay while you wait, undervalued now but historically strong. Not for quick wins — built for patient investors.
0 · Reply
Makingmillions192
Makingmillions192 Jan. 18 at 3:57 AM
$LEXX Don’t forget what happened last time we were here and started promo on CNBC 👀 This time we have phase 1b under our belt with a pending MTA deal in the works and multiple other pharma companies talking with us. 2026 has the makings to be a massive year here!! Buy and hold like the big boys are doing!! 💰 $NVO $PFE $LLY
1 · Reply